Catching up on new innovations for Allergan, an AbbVie company

Jag Dosanjh, senior vice president of U.S. Eye Care, Allergan, an AbbVie company, offers a preview of the company's latest innovations, developments, and what attendees can look forward to at ASCRS 2021.


See more ASCRS coverage

Related Videos
Related Content

COPHy 2023: Traveling the path to new restorative therapies

March 24th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

APAO 2023: Keralink trial: Efficacy and safety of corneal cross-linking for children with Keratoconus

February 25th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

APAO 2023: Diffuse atrophy in children may be link to development of pathologic myopia in adults

February 24th 2023

APAO 2023: Tenaya and Lucerne studies 1 year results: A closer look at anatomic outcomes In matched comparison

February 23rd 2023

COPHy 2023: Traveling the path to new restorative therapies

March 24th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

APAO 2023: Keralink trial: Efficacy and safety of corneal cross-linking for children with Keratoconus

February 25th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

APAO 2023: Diffuse atrophy in children may be link to development of pathologic myopia in adults

February 24th 2023

APAO 2023: Tenaya and Lucerne studies 1 year results: A closer look at anatomic outcomes In matched comparison

February 23rd 2023

COPHy 2023: Traveling the path to new restorative therapies

March 24th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

APAO 2023: Keralink trial: Efficacy and safety of corneal cross-linking for children with Keratoconus

February 25th 2023

Impact of prior authorization for cataract surgery

August 16th 2021

APAO 2023: Diffuse atrophy in children may be link to development of pathologic myopia in adults

February 24th 2023

APAO 2023: Tenaya and Lucerne studies 1 year results: A closer look at anatomic outcomes In matched comparison

February 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.